Medtronic (MDT) Results Match Preannouncement Commentary, UBS Reiterates Buy Rating
- U.S. stocks close down on news of Biden tax proposal
- Biden To Propose Capital Gains Tax As High As 43.4% For Wealthy - Bloomberg
- Intel (INTC) Tops Q1 EPS by 24c, Offers Guidance
- Snap (SNAP) Tops Q1 EPS by 5c, DAUs were 280 million, Offers Guidance
- Credit Suisse (CS) Falls 6% on 'Unacceptable Loss' as Exposure to Archegos Grew to More Than $20 Billion, Set to Raise Over $2 Billion to Support Liquidity
News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.
UBS analyst Matthew Taylor reiterated a Buy rating and $130.00 price target on Medtronic (NYSE: MDT) after the company reported FY3Q21 results (Jan), with sales of $7.78B -1% organic (cons.$7.77B) and EPS of $1.29 (-10%) vs. cons. $1.15. On January 11, management noted that results could be roughly flat instead of flat to slightly up due to impact from CV-19 surges in Dec. and Jan and the reported -1% organic decline matched these statements. Despite this, MDT noted q/q improvements in revenue and earnings and cited continued share gains in an increasing number of businesses.
The analyst stated "We reiterate our Buy rating on shares of MDT and continued to be impressed by the company's progress in a number of segments, showing strong relative performance and execution during the pandemic; we are excited about MDT's pipeline as well."
Shares of closed at $118.00 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wedbush Said Q1 Estimates for Tesla (TSLA) 'Very Beatable'
- Bankinter, S.A. (BKT:SM) (BKIMF) PT Raised to EUR4.40 at Societe Generale
- Umicore SA (UMI:BB) (UMICY) PT Raised to EUR35 at JPMorgan
Create E-mail Alert Related CategoriesAnalyst Comments, Analyst EPS Change, Analyst EPS View
Related EntitiesUBS, Earnings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!